United States · FDA National Drug Code directory
Metaxalone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-898_4fa17239-3e4c-a50f-e063-6394a90a4de5
- Product NDC
- 76420-898
- Form
- TABLET
- Composition / generic term
- Metaxalone
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170619
- Source listing expiry
- 20271231
Source-listed ingredients
- METAXALONE — 800 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (76420-898-01) · 76420-898-01
- 12 TABLET in 1 BOTTLE (76420-898-12) · 76420-898-12
- 15 TABLET in 1 BOTTLE (76420-898-15) · 76420-898-15
- 20 TABLET in 1 BOTTLE (76420-898-20) · 76420-898-20
- 30 TABLET in 1 BOTTLE (76420-898-30) · 76420-898-30
- 60 TABLET in 1 BOTTLE (76420-898-60) · 76420-898-60
- 90 TABLET in 1 BOTTLE (76420-898-90) · 76420-898-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →